Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development

Juliana Inês Santos1, Ana Luísa Teixeira, Francisca Dias

  • 1Molecular Oncology Group, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.

Insights

Transforming growth factor β1 (TGFβ1) pathway loss drives prostate cancer (PC) progression. Smad proteins regulate microRNAs (miRNAs), offering potential therapeutic targets for PC metastasis by restoring specific miRNA expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PC) is a leading cancer diagnosis in men, often linked to the dysregulation of the transforming growth factor β1 (TGFβ1) signaling pathway.
  • Loss of TGFβ1 pathway activation in PC promotes tumor growth, proliferation, and resistance to apoptosis.
  • MicroRNAs (miRNAs) are implicated in cancer development, invasion, and metastasis.

Purpose of the Study:

  • To review the mechanisms of Smad-mediated regulation of miRNA biogenesis.
  • To elucidate the role of these mechanisms in cancer development, specifically in prostate cancer.
  • To identify key TGFβ1-related miRNAs involved in prostate cancer metastasis.

Main Methods:

  • Literature review focusing on Smad proteins, miRNA biogenesis, and prostate cancer.
  • Analysis of transcriptional and posttranscriptional regulation of miRNAs by Smad proteins.
  • Identification of specific miRNAs associated with TGFβ1 signaling and PC metastasis.

Main Results:

  • Smad proteins regulate miRNA expression through both transcriptional and posttranscriptional pathways.
  • Dysregulation of TGFβ1 signaling in PC impacts miRNA expression profiles.
  • Specific miRNAs, including miR-143, miR-145, miR-146a, and miR-199a, are identified as key players in PC metastasis.

Conclusions:

  • Smad-mediated regulation of miRNAs is crucial in prostate cancer development and metastasis.
  • Restoring the expression of TGFβ1-related miRNAs presents a promising therapeutic strategy for prostate cancer treatment.
  • Targeting miRNA pathways offers a novel approach for managing PC progression and metastasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K